West Pharmaceutical Services Inc (WST)

NYSE
Currency in USD
336.34
-0.86(-0.26%)
Closed
After Hours
336.340.00(0.00%)
WST Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
335.15340.97
52 wk Range
265.00413.70
Key Statistics
Edit
Prev. Close
337.2
Open
340
Day's Range
335.15-340.97
52 wk Range
265-413.7
Volume
610.31K
Average Volume (3m)
587.93K
1-Year Change
-1.9%
Book Value / Share
37.94
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WST Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
379.85
Upside
+12.94%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 32 consecutive years
Show more

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Compare WST to Peers and Sector

Metrics to compare
WST
Peers
Sector
Relationship
P/E Ratio
48.8x7.5x−0.6x
PEG Ratio
−5.340.120.00
Price/Book
8.9x3.1x2.6x
Price / LTM Sales
8.5x2.3x3.1x
Upside (Analyst Target)
12.3%20.6%53.0%
Fair Value Upside
Unlock−10.4%8.0%Unlock

Analyst Ratings

9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 379.85

(+12.94% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.81
Dividend Yield
0.25%
Industry Median 0.72%
Annualised payout
0.8400
Paid quarterly
5-Years Growth
+5.92%
Growth Streak

Earnings

Latest Release
Oct 24, 2024
EPS / Forecast
1.85 / 1.50
Revenue / Forecast
746.90M / 709.30M
EPS Revisions
Last 90 days

FAQ

What Is the West Pharmaceutical Services (WST) Stock Price Today?

The West Pharmaceutical Services stock price today is 336.34.

What Stock Exchange Does West Pharmaceutical Services Trade On?

West Pharmaceutical Services is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for West Pharmaceutical Services?

The stock symbol for West Pharmaceutical Services is "WST."

Does West Pharmaceutical Services Pay Dividends? What’s The Current Dividend Yield?

The West Pharmaceutical Services dividend yield is 0.25%.

What Is the West Pharmaceutical Services Market Cap?

As of today, West Pharmaceutical Services market cap is 24.36B.

What is West Pharmaceutical Services Earnings Per Share?

The West Pharmaceutical Services EPS is 6.81.

What Is the Next West Pharmaceutical Services Earnings Date?

West Pharmaceutical Services will release its next earnings report on 12 Feb 2025.

From a Technical Analysis Perspective, Is WST a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.